Skip to main content
Equibles

Ronald E. Osman

Board Member

Inhibitor Therapeutics, Inc. (INTI)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ronald E. Osman

Ronald E. Osman is recorded as Board Member at Inhibitor Therapeutics, Inc. (INTI). Inhibitor Therapeutics, Inc. reported in an 8-K filed September 18, 2026 that Ronald E. Osman was appointed Director, effective September 15, 2026. Inhibitor Therapeutics, Inc. reported in an 8-K filed August 29, 2023 that Ronald E. Osman was appointed Director (non-independent director), effective August 23, 2023.

“Francis E. O'Donnell, Samuel J. Sears, Niraj Vasisht, Michelle Yanez, Michael Jerman and Ronald E. Osman were each elected to serve on the Board of Directors (the "Board") for a one-year term that expires at the 2027 Annual Meeting of Stockholders, or until their earlier death, resignation or removal and their successors are elected and qualified.”
Inhibitor Therapeutics, Inc. Form 8-K, filed September 18, 2026 · Read the filing
“On August 23, 2023, the Board of Directors (the "Board") of Inhibitor Therapeutics, Inc. (the "Company") increased the number of directors on the Board from four (4) members to seven (7) members and appointed Ronald E. Osman to fill one of the vacancies of the Board.”
Inhibitor Therapeutics, Inc. Form 8-K, filed August 29, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Inhibitor Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.